Jula Inrig, Chief Medical Officer: Travere Therapeutics TVTX Sell · Filed 25/02/12

Trade details

Type: Insider sale
Amount: $60,425.04
Shares · price: 2,568 sh · $23.53 a share
Held after: 89,602 sh
Stock: Travere Therapeutics TVTX
Person: Jula InrigChief Medical Officer
Trade date: 25/02/12
Filed: 25/02/12
Days to filing: 0 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/13~25/03/14

Jula Inrig's recent trades

Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$2.9M
44,674 sh
$2.9M
Filed 09/15
Traded 09/15
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$900K
20,000 sh
$900K
Filed 05/06
Traded 05/04
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06
Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06